C. Parmentier

1.3k total citations
33 papers, 760 citations indexed

About

C. Parmentier is a scholar working on Oncology, Hepatology and Pharmacology. According to data from OpenAlex, C. Parmentier has authored 33 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Hepatology and 9 papers in Pharmacology. Recurrent topics in C. Parmentier's work include Drug Transport and Resistance Mechanisms (9 papers), Liver physiology and pathology (8 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). C. Parmentier is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Liver physiology and pathology (8 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). C. Parmentier collaborates with scholars based in France, Germany and Belgium. C. Parmentier's co-authors include Lysiane Richert, Amor Hajri, Audrey Baze, Philippe Bachellier, Bruno Heyd, Magnus Ingelman‐Sundberg, Delilah Hendriks, L. Harivardhan Reddy, Patrick Couvreur and Tracey Hurrell and has published in prestigious journals such as PLoS ONE, Environmental Health Perspectives and International Journal of Molecular Sciences.

In The Last Decade

C. Parmentier

33 papers receiving 742 citations

Peers

C. Parmentier

ONCOL

HEPAT

PHARM

EPIDE

Catherine C. Bell United Kingdom

Huafeng Wang China

Hyuk Jai Jang South Korea

Jianjun Liu China

Jingtao Lu China

Alie de Jager-Krikken Netherlands

Wenxi He China

Yuji Togashi Japan

Junko Satoh Japan

Ruichuang Yang China

Catherine C. Bell United Kingdom

C. Parmentier

265 ×1.3

138 ×0.7

ONCOL

512 ×3.1

HEPAT

339 ×2.2

PHARM

123 ×1.0

EPIDE

Citations per year, relative to C. Parmentier C. Parmentier (= 1×) peers Catherine C. Bell

Countries citing papers authored by C. Parmentier

Since Specialization

Citations

This map shows the geographic impact of C. Parmentier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Parmentier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Parmentier more than expected).

Fields of papers citing papers by C. Parmentier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Parmentier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Parmentier. The network helps show where C. Parmentier may publish in the future.

Co-authorship network of co-authors of C. Parmentier

This figure shows the co-authorship network connecting the top 25 collaborators of C. Parmentier. A scholar is included among the top collaborators of C. Parmentier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Parmentier. C. Parmentier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kent, Lindsey, Kingshuk Roy Choudhury, Stephanie Melching‐Kollmuss, et al.. (2024). P02-30 Generation and evaluation of a historical control database for the creation of assay acceptance criteria for a comparative in vitro hepatic enzyme assay. Toxicology Letters. 399. S116–S116. 1 indexed citations

Niemeijer, Marije, Witold Więcek, Shuai Fu, et al.. (2024). Mapping Interindividual Variability of Toxicodynamics Using High-Throughput Transcriptomics and Primary Human Hepatocytes from Fifty Donors. Environmental Health Perspectives. 132(3). 37005–37005. 10 indexed citations

Kwon, Thérèsa, Sergi Clavé, Christine Piètrement, et al.. (2022). Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France. Archives de Pédiatrie. 29(6). 448–452. 9 indexed citations

Vilas‐Boas, Vânia, et al.. (2021). Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals. International Journal of Molecular Sciences. 22(20). 11005–11005. 12 indexed citations

Braak, Bas ter, Marije Niemeijer, Ruben Boon, et al.. (2021). Systematic transcriptome-based comparison of cellular adaptive stress response activation networks in hepatic stem cell-derived progeny and primary human hepatocytes. Toxicology in Vitro. 73. 105107–105107. 10 indexed citations

Parmentier, C., et al.. (2021). Evaluation of human relevance of Nicofluprole-induced rat thyroid disruption. Toxicology and Applied Pharmacology. 435. 115831–115831. 13 indexed citations

Parmentier, C., Philippe Couttet, Marianne Uteng, Armin Wolf, & Lysiane Richert. (2019). Transcriptomic Analysis of Cholestatic Compounds In Vitro. Methods in molecular biology. 1981. 175–186. 2 indexed citations

Baze, Audrey, C. Parmentier, Delilah Hendriks, et al.. (2018). Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells. Tissue Engineering Part C Methods. 24(9). 534–545. 70 indexed citations

Parmentier, C., Delilah Hendriks, Bruno Heyd, et al.. (2018). Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent. Toxicology Letters. 295. 187–194. 18 indexed citations

10.

Fattah, Sarinj, Maja Matić, Myriam Baes, et al.. (2017). Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype. Pharmaceutical Research. 34(6). 1309–1319. 7 indexed citations

11.

Parmentier, C., Philippe Couttet, Armin Wolf, et al.. (2017). Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes. Archives of Toxicology. 91(8). 2879–2893. 28 indexed citations

12.

Parmentier, C., et al.. (2015). Infections néonatales bactériennes précoces : évaluation des pratiques professionnelles dans 14 maternités d’Île-de-France en 2013. Archives de Pédiatrie. 22(10). 1021–1026. 9 indexed citations

13.

Consiglio, Emma Di, C. Parmentier, Frédéric Y. Bois, et al.. (2015). Understanding the biokinetics of ibuprofen after single and repeated treatments in rat and human in vitro liver cell systems. Toxicology Letters. 233(2). 172–186. 27 indexed citations

14.

Parmentier, C., Rozenn Jossé, Eliane Alexandre, et al.. (2014). Biokinetics of chlorpromazine in primary rat and human hepatocytes and human HepaRG cells after repeated exposure. Toxicology in Vitro. 30(1). 52–61. 22 indexed citations

15.

Parmentier, C., Frédéric Y. Bois, André Guillouzo, et al.. (2014). In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatments. Toxicology in Vitro. 30(1). 36–51. 31 indexed citations

16.

Parmentier, C., et al.. (2013). Oncosuppressive Suicide Gene Virotherapy “PVH1-yCD/5-FC” for Pancreatic Peritoneal Carcinomatosis Treatment: NFκB and Akt/PI3K Involvement. PLoS ONE. 8(8). e70594–e70594. 12 indexed citations

17.

Parmentier, C., S Stanzel, Arno Lukas, et al.. (2013). Transcriptomic Hepatotoxicity Signature of Chlorpromazine after Short- and Long-Term Exposure in Primary Human Sandwich Cultures. Drug Metabolism and Disposition. 41(10). 1835–1842. 32 indexed citations

18.

Alexandre, Eliane, Audrey Baze, C. Parmentier, et al.. (2012). Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers. Xenobiotica. 42(10). 968–979. 29 indexed citations

19.

Parmentier, C., Yves Vandermeeren, Patrice Laloux, & Eric Mormont. (2012). Asymptomatic posterior reversible encephalopathy revealed by brain MRI in a case of axonal Guillain-Barré syndrome. Clinical Neurology and Neurosurgery. 114(7). 1006–1009. 8 indexed citations

20.

Wack, Séverine, et al.. (2007). Telomerase Transcriptional Targeting of Inducible Bax/TRAIL Gene Therapy Improves Gemcitabine Treatment of Pancreatic Cancer. Molecular Therapy. 16(2). 252–260. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact